Reversible neurotoxicity during interleukin-2 therapy for metastatic renal cell carcinoma.

van Laar, J M

Reversible neurotoxicity during interleukin-2 therapy for metastatic renal cell carcinoma. [electronic resource] - European journal of cancer (Oxford, England : 1990) Oct 1995 - 1895-7 p. digital

Publication Type: Case Reports; Letter

0959-8049

10.1016/0959-8049(95)00297-v doi


Brain--drug effects
Carcinoma, Renal Cell--secondary
Female
Humans
Interleukin-2--adverse effects
Kidney Neoplasms--pathology
Magnetic Resonance Imaging
Middle Aged
Ovarian Neoplasms--secondary